Expression of CT-X antigens in ITGCN

Slides:

Advertisements

Similar presentations

Sam Stern 8,590 new cases deaths Rate increase.

Advertisements

Transcription Factor GATA-4 Is Expressed in Pediatric Yolk Sac Tumors

PTEN Mutational Spectra, Expression Levels, and Subcellular Localization in Microsatellite Stable and Unstable Colorectal Cancers Xiao-Ping Zhou, Anu.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Primary cutaneous mucinous carcinoma of the breast

Thomas Kirchner, Thomas Brabletz The American Journal of Pathology

Immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) analysis of MET and KRAS. For IHC, the specific MET antibody (Met (D1C2) XP Rabbit.

Volume 44, Issue 3, Pages (September 2003)

The Case ∣ Acute renal failure and anemia

Cliques and Schisms of Cancer Genes

Immunohistochemistry of CD8 (A and B) and PD-L1 (C–F).

PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.

Kuo-Chung Lan, M. D. , Chang-Yi Hseh, M. Sc. , Sheng-Yun Lu, M. D

Diagnostic Value of Albumin Gene Expression in Liver Tumors: Case Report and Review of the Literature S. Vincent Rajkumar, M.D., Ronald L. Richardson,

IHC staining of FFPE esophageal tissues in tissue microarrays (×20).

Cysteine cathepsins (proteases)—On the main stage of cancer?

Representative multiplex immunofluorescence image of synovial sarcoma with increased PD-L1/PD-1/CD8 cell densities at the tumor-invasive margin demonstrating.

Volume 122, Issue 1, Pages (January 2002)

Expression of THBS2 in human PanIN tissue and PDAC tumor tissue

Human Papillomavirus Gene Expression in Cutaneous Squamous Cell Carcinomas from Immunosuppressed and Immunocompetent Individuals Karin J. Purdie, Thirunavukarasu.

Cutaneous spindle cell carcinoma misdiagnosed as atypical fibroxanthoma based on immunohistochemical stains Anastasia Benoit, MD, Joshua Wisell, MD,

(A–C) Electron microscopic images obtained from two different cases, (A) a cluster of large malignant cells with cytoplasmic mucin vacuoles consistent.

Expression of apocrine markers at various stages of apocrine carcinoma progression. Expression of apocrine markers at various stages of apocrine carcinoma.

The summary page for cancer profiles.

NICD1 immunohistochemical staining in normal and tumor tissue.

Src acetylation is critical for its tumorogenesis property.

A, DEAR1 and SMAD3 immunohistochemical staining in human breast cancer tissues. A, DEAR1 and SMAD3 immunohistochemical staining in human breast cancer.

Dermal cells from human neonatal foreskin can be distinguished into fibroblasts and pericytes based on differential VLA-1 expression. Dermal cells from.

SIRT1 is downregulated in human gastric cancer (GC).

Disruption of the tubule formation by immortalized cells during nephrogenesis in vitro. Disruption of the tubule formation by immortalized cells during.

Fig. 4. Pathologic findings of Case 2

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

Mice immunized twice with RRBC showed superior protection to tumor challenge with αGal-positive MC38 colon carcinoma cells compared with mock-immunized.

Immunochemical staining for HMBG3 in normal cervix, CIN III and invasive carcinomas and could show absent staining in normal cervix (A), absent to weak.

Specificity of HOM-MEL-40/SSX2 p stimulated CD8+ T-cells.

Geographic colocalization of PD-L1+ tumor cells with infiltrating immune cells in MCC. The predominant pattern of tumor cell PD-L1 expression is at the.

Expression profile of RSPO1 and 2 in gastric cancer.

FAK overexpression in invasive human breast cancer and DCIS

FAK overexpression in invasive human colon cancer and colon dysplasia.

IL6 mRNA is not detected in metastatic prostate cancer cells.

AXL is not expressed in human prostate tumors.

MPGES is expressed in epithelial cells in benign and malignant tumors of the colon. mPGES is expressed in epithelial cells in benign and malignant tumors.

Cytofluorometry analysis demonstrating the specific coating of anti-tumor Fab-HLA-A2/Flu conjugates on the surface of HLA-A2 negative tumor target cells,

Immunohistochemical analysis of dUTPase in human breast adenocarcinoma

Expression of XCR1 in normal ovarian surface epithelium and the IOSE and borderline EOC cell lines. Expression of XCR1 in normal ovarian surface epithelium.

Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.

Example inverse FF-OCT images (left column) and corresponding histology images (right column) of ovarian metastases. Example inverse FF-OCT images (left.

Immunohistochemical staining for FOXO3a of breast cancer tumor tissues

Representative FFPE sections of subcutaneous xenografts derived from HBEC3p53,KRAS and HBEC3p53,KRAS,MYC. Representative FFPE sections of subcutaneous.

Reduced klotho expression in pancreatic cancer.

Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8 and Stat3+/+:HPV8 mice. Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8.

CD24 expression. CD24 expression. A, By global gene expression, CD24 is found to be highly upregulated in SEF (80×) and in LGFMS (37×) as compared with.

GATA-3 immunostaining was scored semiquantitatively; tumors with

Histology (H&E; original magnification, ×100 for B-2P/C-12P/C-64P and ×40 for C-10P; top) of small-sized lung adenocarcinomas and immunohistochemical staining.

Specific reaction with MIB1, M30, and CD31 monoclonal antibodies in primary human cervical carcinoma before (A, C, and E) and after (B, D, and F) Tam treatment.

The CCR5+ population of SUM-159 cells is enriched with tumor-initiating cells. The CCR5+ population of SUM-159 cells is enriched with tumor-initiating.

CTLA-4 and PD-1 modulate different aspects of the T-cell response: A, CTLA-4 is upregulated after antigen-specific activation of a naïve or memory T cell.

Immune response of CEA-transgenic mice transferred with OT-1 splenocytes and immunized with ovalbumin and adjuvant. Immune response of CEA-transgenic mice.

Immunofluorescence (A-C) and IHC (D-G) analysis of XAGE-1b.

Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.

In situ expression of signature genes in the Th1, Th2, Th17, and Treg pathways. In situ expression of signature genes in the Th1, Th2, Th17, and Treg pathways.

Fig. 5 Distributions of cell nuclear area values and internuclear distances in the breast tumor specimens (Figs. 3 and 4), where bin interval = 8 and n.

Fig. 4 In vivo siRIPK4 delivered by HNTs inhibits tumor promotion of T24 bladder cancer cells in an in situ model of bladder cancer (n = 12 rats in each.

Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.

Immunohistochemical determination of TIM-3 expression in ccRCC.

CD36 expression is coordinately regulated in multiple cellular compartments. CD36 expression is coordinately regulated in multiple cellular compartments.

CD36 expression in tissue adjacent and distal to the tumor.

Immunoblotting of human cancer cell lines pretyped by RT-PCR for CT10/MAGE-C2 mRNA expression with mAb LX-CT10.5 (NP-40 detergent lysates, chemiluminescence.

IHC staining of FFPE esophageal tissues in tissue microarrays (×20).

GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.

Presentation transcript:

Expression of CT-X antigens in ITGCN Expression of CT-X antigens in ITGCN. Seminiferous tubules in two different cases of seminoma showed possible ITGCN (A and C). Expression of CT-X antigens in ITGCN. Seminiferous tubules in two different cases of seminoma showed possible ITGCN (A and C). Using OCT3/4 (nuclear, brown) and CT7 (cytoplasmic, red) dual staining, one case (B) showed ITGCN with mutually exclusive expression between CT7-negative; OCT3/4-positive ITGCN cells; and CT7-positive, OCT3/4-negative residual spermatogonia in the same tubules, whereas the other case (D) showed only spermatogonia (i.e., CT7-positive, OCT3/4negative), negative for ITGCN. The invasive component of this second tumor (D, on the right) was OCT3/4-positive and CT7-negative. In most CT-X positive cases (E, a case of CT7-positive mixed embryonal carcinoma and yolk sac tumor), the ITGCN component (F, OCT3/4-positive cells in brown) was negative for CT-X expression (CT7, red). However, CT-X-positive ITGCN cells could be identified in some cases, evidenced by co-expression of OCT3/4 and CT7 (E) [or OCT3/4 and MAGE-A (F)], co-existing with CT-X-negative ITGCN cells. (Magnification, 400X). Yao-Tseng Chen et al. Cancer Immun 2013;13:10 Copyright © 2013 by Yao-Tseng Chen